Displaying 1 - 20 of 58
CVS Corporation, and Revco D.S., Inc.
CVS agreed to settle allegations that its acquisition of Revco would substantially reduce competition for the retail sale of pharmacy services to health insurance companies and other third-party payers in Virginia and in the Binghamton, New York metropolitan area. The consent order requires the divestiture of 114 Revco stores in Virginia and 6 pharmacy counters in Binghamton.
In March, 1998, CVS Corporation agreed to pay a $600,000 civil penalty to settle Federal Trade Commission charges that the company violated a 1997 consent order and asset maintenance agreement it signed with the agency to settle charges stemming from CVS's 1997 acquisition of Revco D.S., Inc.
FTC and DOJ Host Listening Session on Lowering Americans’ Drug Prices Through Competition
FTC and DOJ Host Listening Session on Lowering Americans’ Drug Prices Through Competition
FTC and DOJ Host Listening Session on Lowering Americans’ Drug Prices Through Competition
FTC and DOJ to Host Listening Sessions on Lowering Americans’ Drug Prices Through Competition
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Statement of Chair Lina M. Khan In the Matter of Cooperativa de Farmacias Puertoriqueñas
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
FTC Seeks Public Comments on Cooperativa De Farmacias Puertorriqueñas Request to Modify Final Commission Order
FTC Reaches Proposed Settlement with Surescripts in Illegal Monopolization Case
FTC Announces Tentative Agenda for July 20 Open Commission Meeting
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Displaying 1 - 20 of 58